| Value | ₹2,000 Cr |
|---|
NSE filing, NSE: MANINFRA. Summary written from the filing by ALFA Finder's alert engine.
Man Infraconstruction Ltd: key numbers
- Share price
- ₹106.79
- Market cap
- ₹4,311 Cr
- Revenue (annual)
- ₹630.5 Cr
- Net profit (annual)
- ₹200.6 Cr
- P/E (TTM)
- 19.2×Sector 32.2×
- Promoter holding
- 62.52%+0.00% QoQ
- FII holding
- 1.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Man Infraconstruction Ltd
All →Man Infraconstruction Capital Structure Change
Man Infraconstruction bought back 67,000 equity shares on October 30, 2026 at an average price of Rs.106.93. Total buyback so far is 1,04,17,000 shares.
- Value
- ₹0.72 Cr
Man Infraconstruction Capital Structure Change
Man Infraconstruction bought back 40,000 equity shares on October 29, 2026 via Nirmal Bang on NSE at an average ₹111.1898. Cumulative buyback reached 1,03,50,000 shares under the open-market programme.
- Value
- ₹0.44 Cr
Man Infraconstruction Other Announcement
Man Infraconstruction filed a Reg 32 quarterly statement confirming no deviation in use of preferential-warrant proceeds. No deviation or variation arose for the quarter ended September 30, 2026.
Man Infraconstruction Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹266 Cr (+57% YoY), PAT ₹62.8 Cr (+14%); H1 revenue ₹484 Cr (+30%), PAT ₹134.4 Cr (+21%). Godrej Marine Lines deal unlocks ₹6,000+ Cr GDV.
Man Infraconstruction Results Update
Man Infraconstruction reported consolidated PAT of ₹63 crores in Q2FY27, up 14% YoY, and ₹134 crores for H1FY27, up 21%. Revenue and sales momentum remained strong across its EPC and real estate verticals.
Man Infraconstruction Q2 FY27 Results: Net Profit ₹65.2 Cr, Up 8.7% YoY
Man Infraconstruction Ltd reported revenue from operations of ₹266 Cr (+57.2% YoY) and net profit of ₹65.2 Cr (+8.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹65.2 Cr · +8.7% YoY
Other regulatory approval announcements
All →Nesco Regulatory Approval
Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.
Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.